Peptide
FOXO4-DRI
The senescent cell disruptor
A peptide that selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 interaction. Represents targeted senolytic therapy.
Mechanisms
- Senescent cell targeting
- p53 release
- Selective apoptosis induction
Dosing
Typical dose
2–5mg
Timing
Intermittent dosing protocols. Often cycled monthly.